ACT Press Releases and the NY Times
The ACT flap is one of those stories that will dog embryonic stem cell research for years – regardless of the merits or the lack of merits of the issue. One reason is that ESC research foes will not let it die.
The latest chapter, however, came in the New York Times with a related press release from ACT, the Alameda, Ca., firm whose research triggered t…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.